Gregory D. Gorgas

CIK: 0001526251

Transaction Breakdown

Open Market Buys (P)1 (12.5%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (37.5%)

Compensation grants

Other (G, F, J, C, D, …)4 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ARTL

ARTELO BIOSCIENCES, INC.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (8 total)

ARTL
ARTELO BIOSCIENCES, INC.
Jan 29, 2026
Award(A)
Stock Options (right to buy)
Direct
154.7K shares-
ARTL
ARTELO BIOSCIENCES, INC.
Oct 28, 2025
Conversion(C)
Warrant (right to buy)
Direct
9.6K shares-
ARTL
ARTELO BIOSCIENCES, INC.
Oct 28, 2025
Conversion(C)
Warrant (right to buy)
Direct
18K shares-
ARTL
ARTELO BIOSCIENCES, INC.
Oct 28, 2025
Conversion(C)
Convertible Promissory Note
Direct
0 shares at avg. $27710.00-
ARTL
ARTELO BIOSCIENCES, INC.
Oct 28, 2025
Conversion(C)
Convertible Promissory Note
Direct
0 shares at avg. $35000.00-
ARTL
ARTELO BIOSCIENCES, INC.
Jul 2, 2025
Award(A)
Stock Option (right to buy)
Direct
20K shares-
ARTL
ARTELO BIOSCIENCES, INC.
Jul 2, 2025
Award(A)
Stock Option (right to buy)
Direct
20.4K shares-
ARTL
ARTELO BIOSCIENCES, INC.
May 1, 2025
Purchase(P)
Convertible Promissory Note
Direct
0 shares at avg. $35000.00-

		Type	Shares	Price		Ownership
Jan 29, 2026	ARTL ARTELO BIOSCIENCES, INC.	Award(A) Stock Options (right to buy)	154,713	-	-	Direct
Oct 28, 2025	ARTL ARTELO BIOSCIENCES, INC.	Conversion(C) Warrant (right to buy)	9,586	-	-	Direct
Oct 28, 2025	ARTL ARTELO BIOSCIENCES, INC.	Conversion(C) Warrant (right to buy)	17,952	-	-	Direct
Oct 28, 2025	ARTL ARTELO BIOSCIENCES, INC.	Conversion(C) Convertible Promissory Note	0	$27710.00	-	Direct
Oct 28, 2025	ARTL ARTELO BIOSCIENCES, INC.	Conversion(C) Convertible Promissory Note	0	$35000.00	-	Direct
Jul 2, 2025	ARTL ARTELO BIOSCIENCES, INC.	Award(A) Stock Option (right to buy)	20,000	-	-	Direct
Jul 2, 2025	ARTL ARTELO BIOSCIENCES, INC.	Award(A) Stock Option (right to buy)	20,393	-	-	Direct
May 1, 2025	ARTL ARTELO BIOSCIENCES, INC.	Purchase(P) Convertible Promissory Note	0	$35000.00	-	Direct

1-8 of 8 transactions

About Gorgas Gregory D.

Gorgas Gregory D. (SEC CIK 0001526251) files insider reports with the SEC as Pres, CEO, CFO, Treas & Secr of ARTELO BIOSCIENCES, INC. (ARTL).

Signal8 holds 4 ownership filings by Gorgas Gregory D., all Form 4s, filed between May 5, 2025 and Feb 2, 2026. Those filings report 8 transactions, from May 1, 2025 to Jan 29, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Gorgas Gregory D.'s filings is in SOLANA BEACH, CA.

Recent filings by Gorgas Gregory D.

Jan 29, 2026: Grant or award of ARTL derivative securities (Form 4, code A).
Oct 28, 2025: Conversions of ARTL derivative securities (4 lines, Form 4, code C).
Jul 2, 2025: Grants or awards of ARTL derivative securities (2 lines, Form 4, code A).
May 1, 2025: Open-market purchase of ARTL derivative securities (Form 4, code P).

Other insiders filing for ARTELO BIOSCIENCES, INC. (ARTL)

MATSUI CONNIE, Director
Blayney Douglas, Director
Reyes Gregory, Director
EMANUELE ROBERT MARTIN, Director
Kelly Steven, Director
FAVORITO TAMARA A, Director

How to read Form 4 transaction codes